Sunday, October 21, 2012

CAP Assists Awardees

The NIH Commercialization Assistance Program (CAP) is a specialized technical assistance program for SBIR/STTR Phase II awardees. CAP is designed to help promising small life science and healthcare companies develop their commercial businesses and transition their SBIR/STTR developed technologies into the marketplace.

Assisting small businesses is a top priority for NIH to ensure the success of the SBIR/STTR program and to maximize the agency’s investment. The program is managed through a contract with Humanitas, Inc. at of Silver Spring MD that has teamed up with Larta Inc at located in Los Angeles.

The plan is for CAP to provide selected participants with individualized assistance toward accomplishing their commercialization goals. This is to be achieved through individual mentoring and consulting sessions, training workshops, access to domain experts, and discussions on how to focus on outcomes that will enhance the commercialization profile and readiness of participating grantees.

Two parallel tracks are offered to provide assistance:

  • The Commercialization Training Track (CTT) assists participants evaluate their commercialization options based on their specific technologies and to develop a solid market-entry plan covering an 18 month period. Help is also provided to develop market appropriate tools to accomplish these objectives
  • The Accelerated Commercialization Track (ACT) applies to a select group of NIH SBIR/STTR Phase II companies who have successfully commercialized or sold products and/or services, generated revenue, established partnerships, and/or otherwise achieved a level of market development that is sustainable over a definitive period.
 The application deadline for CAP is November 7, 2012 and Awardees will be selected November 21, 2012.  

For inquiries at NIH, email, for inquires at Humanitas Inc. email Lura Myers at, and for technical assistance, email Judy Hsieh at For general information and news, go to